Insulin Access: Price Caps

Patients Win: How #insulin4all Advocates Helped make insulin more affordable

6 Apr 2026, 3:07 p.m. in Content Type: News & Statements, Country: United States, Insulin Access: Price Caps by T1International

Insulin has long been unaffordable for many people in the United States, even though the cost to produce most insulin vials remains between $3 and $6. Over the past few decades, prices have skyrocketed, with “the Big Three” insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi, controlling nearly all of the U.S. insulin market and raising prices in lockstep. Thanks to persistent advocacy and legal action, we have won a significant victory in holding intermediaries accountable for practices that drove up insulin costs.
Read more

A Trillion-Dollar Company and a $687 Vial: My Conversation with Eli Lilly

12 Jan 2026, 8:02 p.m. in Content Type: Advocacy Stories, Country: United States, Insulin Access: Price Caps by Molly King

This blog is a personal story from Molly King, a person living with type 1 diabetes and T1International’s Indiana #insulin4all Chapter co-lead. Molly reflects on her experience rationing insulin and being hospitalized, and she describes a recent conversation with an Eli Lilly executive about insulin pricing. Her story highlights the ongoing reality of insulin rationing, the impact of high list prices, and why T1International remains independent from pharmaceutical company funding while advocating for affordable insulin for everyone, everywhere. Read more

World Diabetes Day 2025: Advocates stand together for Access, Affordability, and Action

16 Nov 2025, 7:39 p.m. in Action & Workshop, Country: Democratic Republic of Congo, Country: Egypt, Country: France, Country: Global, Country: Nigeria, Country: Pakistan, Country: Sierra Leone, Country: South Africa, Country: United States, Insulin Access: Price Caps, Taking on Monopoly Power: Public Pharma, The Right to Full Care: Combatting Discrimination with Education, The Right to Full Care: Glucose Self-Monitoring Supplies, The Right to Full Care: Other Essential Medicine Access & Universal Health Coverage by T1International

On November 14th, 2025, World Diabetes Day, #insulin4all advocates across the globe came together to make a demand: that they be able to access and afford their life-sustaining medications. Recent data showed that 1 in 3 people around the world rationed their insulin due to cost in 2024. At T1International, we know that #insulin4all is a reasonable and dignified demand– and yet, we are still too far from achieving a reality where everyone, no matter where they live, has access to the medicine and supplies they need to survive and flourish. Read more

Global Diabetes Advocates Urge Novo Nordisk’s New CEO to Prioritize People Over Profits

7 Aug 2025, 8:27 p.m. in Content Type: News & Statements, Country: Global, Insulin Access: Price Caps by T1International

T1International Invited to White House Event

22 Apr 2024, 6:21 p.m. in Content Type: Advocacy Stories, Country: United States, Insulin Access: Price Caps, Taking on Monopoly Power: Patent Reform by T1International

T1International advocates, Jesús Morales Sánchez (Communities of Color Working Group Co-Leader), Kristen Whitney Daniels (Federal Working Group Co-Leader), Lib Gatti (USA Advocacy Manager), and Shaina Kasper (Policy and Advocacy Director), were honored to be invited to a recent event at the White House focused on lowering healthcare costs. The event celebrated the success of the access to medicines movement in achieving a $35 monthly cap on out-of-pocket costs for insulin for Medicare Part D beneficiaries, allowing Medicare to negotiate drug prices directly with pharmaceutical companies, and more. Read more

Global Day of Action for #insulin4all demands insulin equity NOW

21 Mar 2024, 3:50 p.m. in Action & Workshop, Country: France, Country: India, Country: Pakistan, Country: Tanzania, Country: United States, Country: Zimbabwe, Insulin Access: Price Caps, Taking on Monopoly Power: Public Pharma, The Right to Full Care: Combatting Discrimination with Education by T1International

On March 16, 2024, hundreds of #insulin4all advocates participated in over a dozen events across the globe calling for insulin access and affordability as part of the Global Day of Action for #insulin4all, sharing their stories on the critical need for insulin equity now. Read more

Promised Price Cuts Not Cutting It: There is No $35 Price Cap on Insulin

11 Jan 2024, 5:16 p.m. in Country: United States, Insulin Access: Price Caps by T1International

The #insulin4all movement has had some major victories lately. For example, Medicare beneficiaries can access $35 copays for some insulins. The list price of insulin went down for nine insulins. Over half of the states in the USA have passed some form of insulin copay cap. These victories were hard fought by #insulin4all advocates over the past decade. But we’re not celebrating the much heralded $35 insulin cap for all. Because it’s not true.
Read more

Advocating To Define “Affordable” for People With Diabetes

10 Nov 2023, 9:47 a.m. in Country: Global, Insulin Access: Price Caps, Organizational Updates, Research by T1International

To kick off Diabetes Awareness Month, the Global Diabetes compact held a two-day meeting where T1International and 35 other organisations in over 25 countries presented the goal of the Fight for Five campaign. We showed the depth and breadth of support for this campaign not only through stories of patients most impacted by lack of affordable and accessible insulin in their home countries, but also by the number of organisations that support a better world for people with diabetes. Read more

Three Reasons Why is Insulin STILL So Expensive

29 Aug 2023, 4:49 p.m. in Contains: Resource, Country: Global, Insulin Access: Alec's Law, Insulin Access: Kevin's Law, Insulin Access: Modern Insulins, Insulin Access: Price Caps, Taking on Monopoly Power: Patent Reform, Taking on Monopoly Power: Public Pharma by Shaina Kasper

Over the past few months, many insulin manufacturers and other entities have announced that they will be lowering the price of insulin in the United States. So, why is insulin still so expensive?
We recently released our Policy Playbook that goes through all of the details and gives advocates the information to push for change locally and nationally. Why insulin is so expensive can be boiled down to three main points. Read more